Profile data is unavailable for this security.
About the company
Mabpharm Ltd is an investment holding company primarily engaged in the research, development and production of monoclonal antibody drugs for cancers and autoimmune diseases. The Company’s main products include CMAB009 Enlituo (cetuximab β injection), CMAB007 Aomaishu (Omalizumab α for Injection), CMAB008 Leiting (infliximab for injection) and other products. The Company’s products are mainly used for colorectal cancer, asthma, urticaria, rheumatoid arthritis, ulcerative colitis in adults and other diseases. The Company is also engaged in the transfer of intellectual property. The Company mainly conducts its business in the domestic market.
- Revenue in HKD (TTM)481.76m
- Net income in HKD-31.23m
- Incorporated2018
- Employees383.00
- LocationMabpharm LtdBlock G79, Lujia Road East, Koutai RoadTaizhou 225300ChinaCHN
- Websitehttp://www.mabpharm.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunho Biologics Inc | 0.00 | -93.28m | 961.93m | 128.00 | -- | 1.76 | -- | -- | -0.6181 | -0.6181 | 0.00 | 3.49 | 0.00 | -- | -- | 0.00 | -14.33 | -- | -15.84 | -- | -- | -- | -- | -- | 6.57 | -- | 0.1242 | -- | -- | -- | 39.74 | -- | -- | -- |
| Brii Biosciences Ltd | 0.00 | -426.94m | 1.05bn | 96.00 | -- | 0.3693 | -- | -- | -0.5865 | -0.5865 | 0.00 | 3.93 | 0.00 | -- | -- | 0.00 | -14.05 | -49.92 | -14.09 | -54.57 | -- | -- | -- | -12,750.27 | -- | -- | 0.003 | -- | -100.00 | -- | -190.66 | -- | -33.13 | -- |
| B&K Corp Ltd | 296.60k | -207.53m | 1.05bn | 100.00 | -- | 10.91 | -- | 3,534.44 | -1.76 | -1.76 | 0.0025 | 0.8165 | -- | -- | -- | -- | -- | -- | -- | -- | 92.34 | -- | -69,968.59 | -- | -- | -- | 0.0371 | -- | -44.70 | -- | -101.78 | -- | -- | -- |
| HighTide Therapeutics Inc | 0.00 | -330.88m | 1.11bn | 57.00 | -- | 2.79 | -- | -- | -0.7319 | -0.7319 | 0.00 | 0.6965 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Kintor Pharmaceutical Ltd | 12.48m | -189.86m | 1.21bn | 136.00 | -- | 4.41 | -- | 96.68 | -0.4389 | -0.4389 | 0.0289 | 0.5485 | 0.0194 | 10.66 | 1.06 | 74,299.69 | -29.53 | -47.72 | -44.54 | -55.96 | -55.12 | -36.16 | -1,521.00 | -8,974.73 | 0.4222 | -33.76 | 0.2881 | -- | -- | -- | 85.36 | -- | -53.11 | -- |
| Wuhan YZY Biopharma Co Ltd | 164.78m | -88.68m | 1.39bn | 106.00 | -- | -- | -- | 8.41 | -0.4575 | -0.4575 | 0.85 | -0.1609 | 0.5805 | 11.54 | 13.96 | 1,458,228.00 | -31.24 | -- | -133.35 | -- | 63.96 | -- | -53.82 | -- | 0.9019 | -24.38 | 1.21 | -- | -- | -- | 49.09 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -253.99m | 1.45bn | 173.00 | -- | -- | -- | -- | -0.4538 | -0.4538 | 0.00 | -0.2891 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 127.39m | -343.97m | 1.53bn | 195.00 | -- | 2.38 | -- | 12.02 | -0.8744 | -0.8744 | 0.3236 | 1.49 | 0.148 | -- | 3,865.48 | 816,606.60 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Cloudbreak Pharma Inc | 78.21m | -327.17m | 1.73bn | 60.00 | -- | -- | -- | 22.07 | -0.39 | -0.39 | 0.0932 | -3.08 | -- | -- | -- | 1,533,510.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| Mabpharm Ltd | 481.76m | -31.23m | 1.77bn | 383.00 | -- | 15.78 | 47.87 | 3.68 | -0.0076 | -0.0076 | 0.1168 | 0.0272 | 0.4209 | 0.4659 | 4.05 | 1,529,387.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Antengene Corp Ltd | 95.86m | -259.78m | 1.96bn | 152.00 | -- | 2.25 | -- | 20.41 | -0.418 | -0.418 | 0.1543 | 1.28 | 0.0619 | 1.51 | 3.20 | 567,217.40 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
| Jiangsu Recbio Technology Co Ltd | 12.39m | -743.11m | 2.17bn | 507.00 | -- | 10.56 | -- | 175.47 | -1.56 | -1.56 | 0.0259 | 0.4262 | 0.006 | -- | -- | 23,325.33 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Frontage Holdings Corp | 1.98bn | 29.99m | 2.24bn | 1.54k | 74.42 | 0.8384 | 7.11 | 1.13 | 0.0148 | 0.0148 | 0.9742 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,268,440.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
| Hanx Biopharmaceuticals (Wuhan) Co Ltd | -100.00bn | -100.00bn | 2.37bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.30 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 58.84m | -1.03bn | 2.39bn | 243.00 | -- | -- | -- | 40.59 | -0.8231 | -0.8231 | 0.0468 | -1.49 | 0.0433 | 0.0547 | 47.89 | 196,118.20 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
Data as of Mar 04 2026. Currency figures normalised to Mabpharm Ltd's reporting currency: Hong Kong Dollar HKD
18.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| CDH Investment Advisory Pte. Ltd.as of 30 Jun 2025 | 742.35m | 18.00% |
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
